Synchrony Financial Form 4 insider transactions
NYSE
Synchrony Financial Director P.W. Parker acquired 14 dividend equivalent units on February 17, 2026, increasing beneficial ownership to 32,789 units.
NYSE
A Synchrony Financial executive sold over 52,000 shares of common stock at $72.32 per share under a pre-arranged trading plan.
NYSE
Synchrony Financial Director Arthur W. Coviello Jr. has scheduled the sale of 4,000 shares of common stock at $72.32 per share on February 2, 2026, under a pre-arranged 10b5-1 trading plan.
NYSE
Synchrony Financial's President and CEO, Brian D. Doubles, acquired 390,751 shares of common stock through the vesting of Performance Share Units, while 181,132 shares were withheld for tax obligations.
NYSE
Synchrony Financial's EVP, CEO of Home & Auto, Curtis Howse, acquired 67,590 shares through PSU vesting and disposed of 29,322 shares for tax purposes.
NYSE
Synchrony Financial's EVP & CEO of Diversified & Value, Courtney Gentleman, acquired 18,313 shares of common stock through PSU vesting and disposed of 6,267 shares for tax obligations.
NYSE
Synchrony Financial's EVP, CEO--Digital, Bart Schaller, acquired 58,939 shares of common stock through PSU vesting, with 23,638 shares withheld for tax.
NYSE
Synchrony Financial's CFO, Brian J. Wenzel Sr., reported the vesting of 87,957 performance share units and the subsequent sale of 40,845 shares for tax obligations.
NYSE
Synchrony Financial's EVP & CEO--Lifestyle, Darrell Owens, acquired 15,213 shares of common stock through PSU vesting, with 4,909 shares withheld for tax.
NYSE
Synchrony Financial's EVP, Chief Risk and Legal Officer, Jonathan S. Mothner, acquired 63,444 shares of common stock through the vesting of Performance Share Units.
NYSE
Synchrony Financial's EVP, CEO of Health & Wellness, Alberto Casellas, acquired 67,590 shares through PSU vesting and disposed of 31,870 shares for tax purposes.
NYSE
Synchrony Financial's EVP, Chief Technology and Operating Officer, Carol Juel, acquired 79,305 shares through PSU vesting and disposed of 34,894 shares for tax obligations.
NYSE
Synchrony Financial Director P.W. Parker acquired 660 shares of common stock through restricted stock units at a price of $83.43 per share, vesting on December 31, 2026.
NYSE
Synchrony Financial Director Fernando Aguirre acquired 660 shares of common stock at $83.43 per share, part of a restricted stock unit grant vesting in 2026.
NYSE
Synchrony Financial Director Laurel Richie acquired 660 shares of common stock through restricted stock units, increasing her beneficial ownership to 49,755 shares.
NYSE
Synchrony Financial Director Daniel O. Colao acquired 660 restricted stock units, set to vest on December 31, 2026.
NYSE
Synchrony Financial Director Deborah G. Ellinger acquired 660 restricted stock units under a pre-arranged plan, vesting fully by December 31, 2026.
NYSE
Synchrony Financial director Kamila K Chytil was granted 660 restricted stock units, vesting fully on December 31, 2026.
NYSE
Synchrony Financial Director Paget Leonard Alves was granted 660 restricted stock units, vesting in December 2026.
NYSE
Synchrony Financial Director Roy A. Guthrie acquired 660 restricted stock units, increasing his direct beneficial ownership in the company.
NYSE
Synchrony Financial Director Jeffrey G. Naylor acquired 1,035 restricted stock units, set to vest on December 31, 2026, at a price of $83.43 per unit.
NYSE
Synchrony Financial Director Arthur W. Coviello Jr. acquired 660 restricted stock units, set to vest on December 31, 2026.
NYSE
Synchrony Financial Director Ellen M Zane acquired 660 restricted stock units at $83.43 per share, which are set to vest fully by December 31, 2026.
NYSE
Synchrony Financial's EVP and CFO, Brian J. Wenzel Sr., is scheduled to receive 294 dividend equivalent units on November 17, 2025.
NYSE
Synchrony Financial's SVP, Chief Accounting Officer and Controller, Amy Tiliakos, acquired 61 dividend equivalent units on November 17, 2025, increasing her beneficial ownership.
NYSE
Synchrony Financial director P.W. Parker acquired 15 dividend equivalent units at $70.47 each, increasing total beneficial ownership to 32,115 units.
NYSE
Synchrony Financial's EVP, CEO of Health & Wellness, Alberto Casellas, increased his beneficial ownership of the company's equity through dividend equivalent units and phantom stock units.
NYSE
Synchrony Financial Director Kamila K Chytil acquired 15 dividend equivalent units on November 17, 2025, valued at $70.47 each.
NYSE
Synchrony Financial Director Fernando Aguirre acquired 15 dividend equivalent units on November 17, 2025, valued at $70.47 each, bringing his total beneficial ownership of DEUs to 27,902.
NYSE
Synchrony Financial director Ellen M. Zane increased her beneficial ownership by acquiring 15 dividend equivalent units, bringing her total to 29,869 units.